| Product Code: ETC11626126 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Canada`s import trend for colorectal cancer drugs in the therapeutic market experienced a decline in growth rate from 2023 to 2024, with a decrease of -14.89%. The compound annual growth rate (CAGR) for the period 2020-2024 stood at 1.02%. This negative import momentum could be attributed to shifts in demand patterns or changes in market dynamics impacting trade flows.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Colorectal Cancer Drugs Therapeutic Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Colorectal Cancer Drugs Therapeutic Market - Industry Life Cycle |
3.4 Canada Colorectal Cancer Drugs Therapeutic Market - Porter's Five Forces |
3.5 Canada Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Canada Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Canada Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Canada Colorectal Cancer Drugs Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of colorectal cancer in Canada |
4.2.2 Growing adoption of targeted therapies and personalized medicine |
4.2.3 Advancements in pharmaceutical research and development |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High costs associated with developing and commercializing cancer drugs |
4.3.3 Potential side effects and safety concerns of colorectal cancer drugs |
5 Canada Colorectal Cancer Drugs Therapeutic Market Trends |
6 Canada Colorectal Cancer Drugs Therapeutic Market, By Types |
6.1 Canada Colorectal Cancer Drugs Therapeutic Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Canada Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Canada Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.1.4 Canada Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.5 Canada Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Canada Colorectal Cancer Drugs Therapeutic Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Canada Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Canada Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.2.4 Canada Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.2.5 Canada Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.2.6 Canada Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Canada Colorectal Cancer Drugs Therapeutic Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Canada Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.3.3 Canada Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 Canada Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Canada Colorectal Cancer Drugs Therapeutic Market Import-Export Trade Statistics |
7.1 Canada Colorectal Cancer Drugs Therapeutic Market Export to Major Countries |
7.2 Canada Colorectal Cancer Drugs Therapeutic Market Imports from Major Countries |
8 Canada Colorectal Cancer Drugs Therapeutic Market Key Performance Indicators |
8.1 Patient survival rates and remission rates |
8.2 Adoption rates of novel therapies and treatment modalities |
8.3 Clinical trial success rates |
8.4 Drug efficacy and safety profiles |
8.5 Healthcare provider and patient satisfaction with treatment options |
9 Canada Colorectal Cancer Drugs Therapeutic Market - Opportunity Assessment |
9.1 Canada Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Canada Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Canada Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Canada Colorectal Cancer Drugs Therapeutic Market - Competitive Landscape |
10.1 Canada Colorectal Cancer Drugs Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 Canada Colorectal Cancer Drugs Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |